Table 1.
Phenotypes | Functions | Stimulator factors | Markers | Excretion | References |
---|---|---|---|---|---|
M1 | Tumor resistance, pro-inflammatory, inhibit proliferation, eliminate pathogens |
IFN-γ, LPS, GM-CSF, TNF-α, iNOS, ROS |
IL-12 (high)/IL-10(low), CD80, CD86, CD60, MMPs, MHCII |
CCL2, CCL3, CCL5, CXCL8, CXCL9, IL-1β, IL-6, IL-23 |
32 |
M2a | Allergy, profibrotic, cell proliferation, anti-inflammatory, wound healing, tumor progression |
IL-4, IL-10, IL-13, (PPAR-γ) |
CD11b, CD45, CD86, CD14, CD206, CD163, CD209, IL-1R, Dectin-1, YM1, RELMα, IGF1, DCIR, Stabilin 1, Factor XIII-A, Ly6C, TREM-2, DC-SIGN, MHCII, Fizz1, Arg-1, YM1/2 |
TGF-β, IL-4, IL-10, VEGF, CCL1, CCL17, CCL18, CCL22, TNF-α, IGF, EPGF |
32–35 |
M2b | Th2 activation, immunoregulation, inflammation, tumor progression | IL-1β, LPS, TLR | CD163, CD14, CD86, MHC-II, IL-10 (high), IL-12 (low), IL-6R | TNF-α, IL-1, IL-6, IL-10, CCL1, SPHK1, LIGHT | 32,35 |
M2c | Immunoregulation, inflammatory response, wound healing, fibrosis | IL-6, IL-10, glucocorticoids, TGF-β, TNF-α | CD163, CD206, CD14, CD16, CD86, CXCR4, MerTK, TLR-1、TLR-8 | IL-10, TGF-β, CCL16, CCL18, CXCL13 | 32,35 |
M2d | Tumor proliferation, invasion, and angiogenesis, immune suppression | IL-6, TLR, Regadenoson, LPS | IL-10 (high), IL-12 (low), VEGF, TNF-α (low), CD163, CD14, CD86 | IL-10, IL-6, TGF-β, VEGF, CCL18, M-CSF | 32 |